Association Between the Implementation of a Population-Based Primary Care Payment System and Achievement on Quality Measures in Hawaii.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
02 07 2019
Historique:
entrez: 3 7 2019
pubmed: 3 7 2019
medline: 17 7 2019
Statut: ppublish

Résumé

Hawaii Medical Service Association (HMSA), the Blue Cross Blue Shield of Hawaii, introduced Population-based Payments for Primary Care (3PC), a new capitation-based primary care payment system, in 2016. The effect of this system on quality measures has not been evaluated. To evaluate whether the 3PC system was associated with changes in quality, utilization, or spending in its first year. Observational study using HMSA claims and clinical registry data from January 1, 2012, to December 31, 2016, and a propensity-weighted difference-in-differences method to compare 77 225 HMSA members in Hawaii attributed to 107 primary care physicians (PCPs) and 4 physician organizations participating in the first wave of the 3PC and 222 233 members attributed to 312 PCPs and 14 physician organizations that continued in a fee-for-service model in 2016 but had 3PC start dates thereafter. Participation in the 3PC system. The primary outcome was the change in a composite measure score reflecting the probability that a member achieved an eligible measure out of 13 pooled Healthcare Effectiveness Data and Information Set quality measures. Primary care visits and total cost of care were among 15 secondary outcomes. In total, the study included 299 458 HMSA members (mean age, 42.1 years; 51.5% women) and 419 primary care physicians (mean age, 54.9 years; 34.8% women). The risk-standardized composite measure scores for 2012 to 2016 changed from 75.1% to 86.6% (+11.5 percentage points) in the 3PC group and 74.3% to 83.5% (+9.2 percentage points) in the non-3PC group (differential change, 2.3 percentage points [95% CI, 2.1 to 2.6 percentage points]; P < .001). Of 15 prespecified secondary end points for utilization and spending, 11 showed no significant difference. Compared with the non-3PC group, the 3PC system was associated with a significant reduction in the mean number of primary care visits (3.3 to 3.0 visits vs 3.3 to 3.1 visits; adjusted differential change, -3.9 percentage points [95% CI, -4.6 to -3.2 percentage points]; P < .001), but there was no significant difference in mean total cost of care ($3344 to $4087 vs $2977 to $3564; adjusted differential change, 1.0% [95% CI, -1.3% to 3.4%]; P = .39). In its first year, the 3PC population-based primary care payment system in Hawaii was associated with small improvements in quality and a reduction in PCP visits but no significant difference in the total cost of care. Additional research is needed to assess longer-term outcomes as the program is more fully implemented and to determine whether results are generalizable to other health care markets.

Identifiants

pubmed: 31265101
pii: 2737174
doi: 10.1001/jama.2019.8113
pmc: PMC6613291
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

57-68

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Health Aff (Millwood). 2018 Jun;37(6):890-899
pubmed: 29791190
N Engl J Med. 2014 Oct 30;371(18):1704-14
pubmed: 25354104
Healthc (Amst). 2018 Sep;6(3):168-174
pubmed: 30001958
Health Aff (Millwood). 2012 Aug;31(8):1885-94
pubmed: 22786651
N Engl J Med. 2016 Jun 16;374(24):2357-66
pubmed: 27075832
N Engl J Med. 2011 Sep 8;365(10):909-18
pubmed: 21751900
N Engl J Med. 2017 May 25;376(21):2004-2006
pubmed: 28538132
Health Aff (Millwood). 2019 May;38(5):794-803
pubmed: 31059355
J Health Econ. 2004 May;23(3):525-42
pubmed: 15120469
N Engl J Med. 2018 Sep 20;379(12):1139-1149
pubmed: 30183495

Auteurs

Amol S Navathe (AS)

Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.
Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.
Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Healthcare Transformation Institute, University of Pennsylvania, Philadelphia.

Ezekiel J Emanuel (EJ)

Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.

Amelia Bond (A)

Weill Cornell Medicine, Cornell University, New York, New York.

Kristin Linn (K)

Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia.

Kristen Caldarella (K)

Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Healthcare Transformation Institute, University of Pennsylvania, Philadelphia.

Andrea Troxel (A)

New York University School of Medicine, New York, New York.

Jingsan Zhu (J)

Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Lin Yang (L)

Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Shireen E Matloubieh (SE)

Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Elizabeth Drye (E)

Yale University School of Medicine, Yale University, New Haven, Connecticut.

Susannah Bernheim (S)

Yale University School of Medicine, Yale University, New Haven, Connecticut.

Emily Oshima Lee (EO)

Hawaii Medical Service Association, Honolulu.

Mark Mugiishi (M)

Hawaii Medical Service Association, Honolulu.

Kimberly Takata Endo (KT)

Hawaii Medical Service Association, Honolulu.

Justin Yoshimoto (J)

Hawaii Medical Service Association, Honolulu.

Isaac Yuen (I)

Hawaii Medical Service Association, Honolulu.

Sheryl Okamura (S)

Hawaii Medical Service Association, Honolulu.

Michael Stollar (M)

Hawaii Medical Service Association, Honolulu.

Jeffrey Tom (J)

Hawaii Medical Service Association, Honolulu.

Michael Gold (M)

Hawaii Medical Service Association, Honolulu.

Kevin G Volpp (KG)

Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.
Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.
Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH